last
decad
advanc
cancer
therapi
led
improv
surviv
children
adolesc
malign
disord
cure
rate
improv
treatmentrel
toxic
especi
infect
account
greater
proport
morbid
mortal
pediatr
hematolog
oncolog
patient
often
highli
suscept
infect
medic
devic
indwel
central
cathet
intermitt
chronic
neutropenia
particularli
high
risk
healthcareassoci
infect
hai
central
lineassoci
bloodstream
infect
clabsi
clostridium
difficil
infect
cdi
ventilatorassoci
pneumonia
vap
catheterassoci
urinari
tract
infect
cauti
respiratori
viral
infect
past
infecti
complic
therapi
oncolog
hematolog
disord
regard
larg
unavoid
recogn
mani
although
common
infect
popul
prevent
collabor
qualiti
improv
effort
led
effect
strategi
reduc
rate
hai
improv
outcom
popul
central
line
central
venou
cathet
prove
invalu
manag
children
cancer
inde
nation
healthcar
safeti
network
nhsn
report
highest
perman
central
line
util
rate
pediatr
gener
hematologyoncolog
hematopoiet
stem
cell
transplant
hsct
ward
unit
also
report
substanti
temporari
central
line
use
clabsi
howev
common
healthcareassoci
infect
hai
affect
pediatr
hematologyoncolog
patient
tabl
list
rel
rate
clabsi
observ
across
differ
patient
popul
cathet
type
adult
contribut
significantli
mortal
hospit
length
stay
cost
microorgan
colon
central
line
often
littl
day
migrat
skin
insert
site
along
extern
surfac
cathet
b
introduct
hub
lumen
manipul
cathet
exposur
contamin
infus
c
hematogen
spread
focal
infect
thrombin
cover
intravascular
portion
cathet
biofilm
produc
mani
microbi
pathogen
promot
adhes
pathogen
risk
subsequ
bloodstream
infect
depend
number
organ
intrins
virul
host
underli
diseas
treatment
characterist
also
contribut
risk
clabsi
mani
institut
unit
state
monitor
rate
inpati
central
line
infect
assess
effect
prevent
effort
center
diseas
control
prevent
nhsn
data
public
report
mani
state
surveil
strategi
also
appli
infect
ambulatori
pediatr
hematolog
oncolog
patient
specif
criteria
bloodstream
infect
develop
cdc
prevent
healthcar
infect
control
practic
advisori
committe
tabl
distinguish
clabsi
infect
occur
patient
central
line
place
day
catheterrel
bloodstream
infect
crbsi
clabsi
specif
laboratori
test
identifi
central
line
sourc
infect
practic
sometim
possibl
implic
exclud
cathet
appropri
laboratori
test
feasibl
eg
central
line
remov
cultur
cathet
tip
therefor
possibl
obtain
eg
simultan
blood
cultur
central
line
peripher
vein
comparison
time
posit
simpler
definit
clabsi
therefor
use
nhsn
surveil
although
recogn
less
specif
desir
figur
success
earli
effort
track
report
prevent
clabsi
last
decad
led
emerg
zero
toler
attitud
toward
clabsi
mani
organ
set
goal
elimin
recogn
pathogen
identifi
blood
cultur
fever
chill
hypotens
associ
common
commens
bacteria
obtain
blood
cultur
drawn
separ
occas
fever
hypothermia
apnea
bradycardia
patient
year
age
associ
common
commens
bacteria
obtain
blood
cultur
drawn
separ
occas
case
organ
identifi
blood
relat
infect
anoth
site
ie
infect
repres
primari
bacteremia
criterion
element
must
take
place
day
day
collect
date
first
posit
blood
specimen
central
lineassoci
bloodstream
infect
clabsi
lcbi
develop
patient
central
line
place
day
onset
infect
infect
seri
intervent
includ
strict
adher
hand
hygien
asepsi
cathet
insert
adher
mainten
bundl
use
appropri
dress
recent
recogn
mani
bloodstream
infect
person
cancer
sever
neutropenia
caus
undergon
hsct
crbsi
result
catheterrel
bloodstream
infect
crbsi
lcbi
addit
laboratori
evid
identifi
central
line
sourc
bloodstream
infect
eg
differenti
time
posit
blood
cultur
mucos
barrier
injuri
lcbi
lcbi
meet
lcbi
criteria
blood
specimen
posit
select
group
recogn
intestin
organ
associ
histori
allogen
hsct
within
year
grade
iii
iv
gastrointestin
gvhd
liter
diarrhea
mlkg
patient
year
age
period
day
collect
date
first
posit
blood
specimen
b
histori
day
anc
wbc
cellsmm
within
day
collect
date
first
posit
blood
specimen
meet
lcbi
criteria
blood
specimen
posit
viridan
group
streptococci
associ
histori
allogen
hsct
within
year
grade
iii
iv
gastrointestin
gvhd
liter
diarrhea
mlkg
patient
year
age
period
day
collect
date
first
posit
blood
specimen
b
histori
day
anc
wbc
cellsmm
within
day
collect
date
first
posit
blood
specimen
patient
year
age
meet
lcbi
criteria
blood
specimen
posit
viridan
group
streptococci
associ
histori
allogen
hsct
within
year
grade
iii
iv
gastrointestin
gvhd
liter
diarrhea
mlkg
patient
yr
age
period
day
collect
date
first
posit
blood
specimen
b
histori
day
anc
wbc
cellsmm
within
day
collect
date
first
posit
blood
specimen
anc
absolut
neutrophil
count
gvhd
graft
versu
host
diseas
hsct
hematopoiet
stem
cell
transplant
lcbi
laboratoryconfirm
bloodstream
infect
wbc
white
blood
cell
count
nation
patient
safeti
network
transloc
gastrointestin
microorgan
bloodstream
particularli
patient
sever
neutropenia
gastrointestin
graft
versu
host
diseas
use
clabsi
surveil
definit
popul
therefor
overestim
proport
bloodstream
infect
attribut
central
line
implic
whether
infect
may
prevent
tradit
approach
inde
infect
prevent
nhsn
introduc
new
surveil
definit
mucos
injuryassoci
laboratoryconfirm
bloodstream
infect
mbilcbi
tabl
addit
studi
impact
distinguish
mbilcbi
clabsi
highrisk
pediatr
adult
popul
ongo
c
difficil
singl
common
organ
caus
hai
unit
state
estim
incid
infect
per
person
overal
per
children
year
age
c
difficil
gramposit
anaerob
sporeform
bacillu
intestin
colon
occur
infecti
spore
may
persist
long
period
environ
ingest
strain
elabor
two
homolog
exotoxin
toxin
toxin
b
bind
damag
intestin
epitheli
cell
incit
strong
inflammatori
respons
north
american
pulsedfield
gel
electrophoresi
type
pcr
ribotyp
strain
toxogen
c
difficil
express
toxin
b
strain
addit
binari
toxin
emerg
earli
commonli
found
north
america
strain
associ
sever
diseas
adult
yet
clear
whether
pathogen
either
children
cancer
patient
order
cdi
occur
patient
must
colon
toxogen
c
difficil
undergo
alter
gastrointestin
microbiom
promot
decreas
microbi
divers
commonli
recogn
risk
factor
data
nation
healthcar
safeti
network
avail
http
wwwcdcgovnhsndatastatindexhtml
cdi
antibiot
use
other
includ
antineoplast
chemotherapi
use
proton
pump
inhibitor
gastrointestin
surgeri
inflammatori
bowel
diseas
immunocompromis
condit
adult
cancer
recipi
hsct
significantli
greater
risk
cdi
gener
hospit
popul
rate
rang
diseas
manifest
rang
mild
diarrhea
fulmin
pseudomembran
coliti
complic
toxic
megacolon
bowel
perfor
sepsi
respons
estim
fatal
rate
adult
malign
also
strong
predictor
recurr
cdi
children
healthcareassoci
cdi
underli
medic
comorbid
malign
common
case
cdi
hospit
children
occur
cancer
rate
tenfold
higher
observ
children
without
cancer
boyl
report
pediatr
hsct
recipi
older
year
age
develop
cdi
within
day
transplant
patient
day
significantli
higher
rate
observ
adult
recipi
sever
complic
diseas
appear
less
common
children
adult
frequent
children
cancer
without
malign
nhsn
defin
healthcareassoci
cdi
posit
test
toxinproduc
c
difficil
unform
stool
specimen
andor
gross
anatom
histopatholog
evid
pseudomembran
coliti
diseas
begin
day
admiss
healthcar
facil
clinic
surveil
definit
signific
limit
may
affect
estim
incid
cdi
pediatr
oncolog
patient
half
young
children
especi
year
age
almost
third
pediatr
oncolog
patient
may
asymptomat
colon
c
difficil
often
long
period
time
investig
suggest
sensit
molecular
diagnost
test
nucleic
acid
amplif
toxin
b
gene
like
overestim
incid
cdi
older
assay
like
identifi
clinic
inconsequenti
carriag
c
difficil
virus
gastrointestin
copathogen
also
detect
mani
children
includ
immunocompromis
children
cdi
make
difficult
judg
contribut
potenti
pathogen
diarrheal
diseas
importantli
howev
patient
colon
toxogen
c
difficil
may
still
repres
sourc
environment
shed
transmiss
infecti
spore
judici
use
antimicrobi
infect
prevent
precaut
environment
clean
mainstay
cdi
prevent
healthcar
set
nhsn
surveil
definit
pneumonia
incorpor
result
diagnost
imag
clinic
sign
symptom
laboratori
test
specif
algorithm
avail
immunocompromis
patient
tabl
ventilatorassoci
pneumonia
vap
defin
pneumonia
occur
calendar
day
patient
place
mechan
ventil
ventil
must
place
day
first
criterion
diagnosi
vap
met
previou
day
precis
incid
clinic
outcom
vap
difficult
establish
studi
use
divers
diagnost
criteria
inconsist
appli
criteria
diagnost
definit
vap
includ
report
nhsn
limit
sensit
specif
sign
symptom
vap
exampl
may
overlap
infect
tracheobronch
noninfecti
pulmonari
disord
reactiv
latent
pulmonari
system
infect
cytomegaloviru
tuberculosi
oncolog
transplant
patient
includ
children
may
indistinguish
vap
featur
current
nhsn
surveil
definit
make
applic
children
problemat
respiratori
specimen
exampl
must
obtain
method
limit
contamin
bronchoalveolar
lavag
may
adapt
technic
limit
greater
risk
young
patient
recogn
limit
vap
surveil
definit
nhsn
surveil
began
assess
broader
rang
ventilatorassoci
event
includ
vap
adult
pediatricspecif
algorithm
vap
yet
avail
one
studi
appli
adult
definit
retrospect
picu
patient
receiv
mechan
ventil
suggest
strategi
may
use
obstacl
diagnosi
notwithstand
vap
second
common
hai
pediatr
neonat
intens
care
unit
unit
state
vap
per
ventil
day
pediatr
medicalsurg
unit
overal
ventil
picu
patient
develop
vap
rate
approxim
threefold
lower
adult
tabl
data
limit
suggest
vap
children
adult
associ
longer
durat
mechan
ventil
picu
stay
greater
hospit
cost
increas
mortal
specif
rate
characterist
vap
pediatr
oncolog
patient
report
plausibl
immunosuppress
might
predispos
infect
increas
rate
sever
vap
popul
pathogenesi
vap
complet
elucid
vap
may
like
convent
pneumonia
result
inhal
infecti
aerosol
complic
hematogen
bacteremia
fungemia
presenc
microorgan
oropharynx
endotrach
aspir
howev
suggest
frequent
potenti
prevent
caus
vap
aspir
microorgan
colon
endotrach
tube
et
oropharynx
stomach
microaspir
upper
airway
secret
around
uncuf
et
commonli
use
infant
children
channel
form
fold
lowpressur
highvolum
cuf
et
may
exacerb
impair
mucociliari
clearanc
pool
secret
subglott
airway
risk
factor
vap
children
includ
prolong
durat
mechan
ventil
prior
antimicrobi
exposur
use
immunosuppress
drug
particularli
corticosteroid
addit
contribut
element
may
includ
replac
usual
microbiolog
flora
oropharynx
stomach
virul
speci
staphylococcu
aureu
gramneg
bacilli
contamin
suction
equip
particularli
associ
use
open
system
nonsteril
solut
presenc
nasogastr
tube
enter
feed
poor
oral
hygien
gastric
distens
posit
semirecumb
posit
associ
lower
risk
vap
supin
posit
contribut
element
pathogenesi
vap
pediatr
hematologyoncolog
patient
studi
prevent
strategi
target
multipl
risk
factor
infect
overal
urinari
tract
infect
uti
fourth
common
hca
infect
unit
state
almost
relat
catheter
instrument
shortterm
indwel
urinari
catheter
may
necessari
acut
urinari
retent
obstruct
need
monitor
urinari
output
especi
periop
critic
ill
receiv
larg
volum
fluid
diuret
prolong
use
may
requir
promot
heal
sacral
perin
wound
incis
incontin
patient
comfort
end
life
care
nhsn
defin
cauti
uti
occur
calendar
day
urinari
cathet
place
day
cathet
remov
applic
rate
gener
higher
children
adult
tabl
littl
report
outcom
children
outsid
intens
care
set
specif
popul
pediatr
hematologyoncolog
transplant
recipi
cauti
associ
secondari
bloodstream
infect
increas
hospit
stay
cost
adult
increas
mortal
cauti
ascend
origin
uropathogen
colon
periurethr
area
adher
fibrinogen
accumul
cathet
multipli
form
biofilm
thereaft
bacteria
may
colon
bladder
often
within
day
releas
toxin
proteas
damag
urinari
epithelium
promot
ascens
kidney
hematogen
dissemin
third
infect
may
occur
contamin
urinari
collect
system
exogen
sourc
hand
healthcar
provid
effort
prevent
cauti
focus
reduc
durat
cathet
use
contamin
drainag
system
respiratori
virus
spread
indirect
contact
droplet
airborn
transmiss
sourc
infect
includ
patient
caregiv
visitor
healthcar
provid
may
asymptomat
symptomat
contamin
environment
sourc
patient
factor
increas
likelihood
healthcareassoci
respiratori
viral
infect
pediatr
hematologyoncolog
transplant
patient
includ
frequent
close
physic
contact
caregiv
young
age
lack
previou
natur
infect
immun
subsequ
acquir
immun
presenc
primari
secondari
immunodefici
ambulatori
healthcar
set
patient
may
care
extend
period
common
area
risk
infect
increas
infecti
person
immedi
recogn
environment
clean
inadequ
time
constraint
strategi
reduc
healthcareassoci
respiratori
viral
infect
includ
transmissionbas
infect
prevent
precaut
vaccin
institut
must
provid
infect
prevent
staff
clinic
microbiolog
support
suppli
equip
necessari
assess
correct
remedi
caus
healthcareassoci
respiratori
viral
infect
risk
assess
inform
develop
process
surveil
manag
endem
epidem
eg
influenza
emerg
eg
middl
east
respiratori
syndromecoronaviru
respiratori
infect
respiratori
hygienecough
etiquett
strategi
design
facilit
prompt
recognit
respiratori
ill
patient
caregiv
develop
intent
incorpor
infect
prevent
standard
precaut
tabl
transmissionbas
precaut
implement
hospit
patient
sign
symptom
respiratori
viral
infect
pend
diagnost
test
singl
patient
room
toilet
hand
hygien
facil
prefer
feasibl
spatial
separ
ft
use
curtain
room
divid
recommend
strategi
cohort
patient
organ
symptom
cohort
provid
consid
outbreak
special
circumst
consult
infect
preventionist
patient
transfer
facil
depart
presenc
potenti
communic
diseas
current
infect
prevent
precaut
commun
receiv
provid
viral
shed
may
persist
week
month
immunocompromis
patient
discontinu
transmissionbas
precaut
popul
therefor
must
consid
host
factor
diseas
epidemiolog
result
diagnost
test
highqual
random
clinic
trial
address
effect
mask
prevent
transmiss
respiratori
virus
exist
evid
suggest
howev
medic
mask
respir
effect
cdc
agenc
recommend
use
devic
protect
patient
healthcar
provid
season
influenza
tuberculosi
clinic
trial
suggest
face
mask
provid
compliancedepend
protect
tabl
respiratori
hygien
cough
etiquett
compon
educ
staff
patient
visitor
regard
respiratori
hygien
cough
etiquett
post
sign
instruct
patient
caregiv
make
healthcar
personnel
awar
symptom
respiratori
ill
provis
materi
sourc
control
eg
tissu
alcoholbas
hand
rub
suppli
handwash
contact
respiratori
secret
mask
spatial
separ
person
respiratori
symptom
other
common
wait
area
ideal
singl
room
minimum
ft
other
observ
droplet
standard
precaut
healthcar
provid
examin
patient
symptom
respiratori
infect
adapt
infect
commun
healthcar
provid
respir
appear
provid
superior
protect
choic
respiratori
protect
base
avail
etiolog
ill
comfort
degre
risk
healthcar
provid
refrain
work
ill
symptom
communic
respiratori
infect
manag
polici
support
discourag
practic
likewis
visitor
respiratori
ill
discourag
enter
healthcar
facil
unless
unavoid
season
influenza
vaccin
healthcar
provid
reduc
hospitalacquir
influenza
infect
cancer
patient
evid
suggest
practic
decreas
employe
morbid
absente
center
diseas
control
prevent
advisori
committe
immun
practic
acip
recommend
unless
medic
contraind
exist
healthcar
personnel
vaccin
annual
protect
famili
patient
influenza
similar
recommend
exist
use
tetanusdiphtheriaacellular
pertussi
tdap
vaccin
prevent
pertussi
recommend
direct
organ
provid
vaccin
part
employe
health
program
make
effort
reduc
administr
financi
barrier
immun
personnel
refus
influenza
vaccin
reason
document
medic
contraind
sign
written
declin
outlin
risk
vaccin
refus
influenza
immun
hcp
track
nhsn
season
employe
healthcar
personnel
acut
care
hospit
receiv
season
influenza
vaccin
repres
signific
increas
histor
rate
complianc
vaccin
recommend
success
strategi
improv
complianc
vaccin
polici
includ
educ
incentivebas
ie
reward
system
effect
approach
mandatori
vaccin
polici
requir
use
protect
face
mask
antivir
prophylaxi
durat
influenza
season
result
suspens
termin
unvaccin
worker
state
enact
legisl
increas
healthcar
provid
immun
rate
process
import
data
element
relat
patient
care
activ
outcom
data
must
systemat
collect
prevent
hai
ongo
process
outcom
data
collect
inform
develop
effect
prevent
strategi
lead
modif
suboptim
process
latest
cdc
surveil
definit
use
identifi
occurr
rate
hai
within
institut
ongo
surveil
reveal
sharp
increas
infect
standard
epidemiolog
investig
techniqu
must
use
investig
outbreak
method
beyond
scope
chapter
organ
remain
open
reevalu
improv
measur
hai
base
new
knowledg
exampl
recent
develop
definit
mbilcbi
clearli
differenti
infect
clabsi
rel
new
outcom
measur
substanti
import
pediatr
hematologyoncolog
popul
consid
process
data
collect
import
identifi
method
util
institut
prevent
occurr
hai
common
approach
infect
prevent
prevent
bundl
design
provid
list
element
routin
implement
prevent
hai
one
identifi
author
inform
prevent
bundl
children
hospit
solut
patient
safeti
sp
intern
network
hospit
aim
reduc
patient
harm
includ
hai
children
hospit
sp
provid
document
includ
prevent
bundl
inform
clabsi
cauti
vap
infect
list
tabl
exampl
element
includ
bundl
focu
standard
insert
mainten
devic
clabsi
cauti
import
process
prevent
vap
note
insert
bundl
element
develop
bedsid
insert
icu
line
placement
oper
room
bundl
element
stratifi
base
level
evid
provid
hospit
guidanc
priorit
effort
sp
document
list
standard
recommend
bundl
element
provid
tool
assess
reliabl
bundl
protocol
audit
perform
sp
prevent
bundl
standard
element
institut
choos
includ
addit
element
desir
gather
data
process
sp
suggest
limit
five
fewer
healthcar
staff
overwhelm
confus
number
intervent
clabsi
cauti
recommend
insert
mainten
bundl
measur
separ
sp
recommend
perform
minimum
audit
per
month
order
obtain
data
frequent
enough
rapidli
identifi
barrier
complianc
make
chang
process
elimin
barrier
complianc
rate
bundl
data
common
goal
within
sp
organ
use
sophist
electron
health
record
ehr
capabl
discret
document
subsequ
retriev
data
may
abl
gather
data
electron
howev
approach
may
feasibl
set
direct
observ
bundl
element
may
identifi
addit
opportun
improv
may
reveal
autom
retriev
data
document
ehr
recommend
practic
includ
structur
investig
data
collect
analysi
episod
infect
effort
may
refer
variou
name
depend
organ
eg
mini
root
caus
analys
rca
line
round
mani
institut
use
approach
document
commonli
clabsi
retrac
everi
step
lead
infect
therebi
identifi
improv
opportun
goal
approach
allow
institut
learn
everi
infect
implement
improv
base
find
exampl
rink
et
al
use
rca
approach
systemat
investig
clabsi
hospit
pediatr
oncolog
patient
posit
blood
cultur
report
multidisciplinari
team
interview
care
provid
analyz
patient
system
factor
could
contribut
clabsi
similar
approach
use
bundi
et
al
multicent
qualiti
improv
collabor
includ
implement
standard
bundl
well
clabsi
survelli
approach
result
signific
reduct
clabsi
rate
among
pediatr
hematologyoncolog
center
instanc
use
rca
approach
provid
vital
data
element
could
use
system
chang
implement
improv
strategi
compar
evid
base
prevent
bundl
discuss
chapter
detail
convinc
data
pediatr
hematologyoncolog
transplant
popul
avail
clabsi
prevent
cauti
vap
bundl
data
support
effect
popul
formal
sp
prevent
bundl
cdi
develop
without
guidanc
approach
must
util
reduc
number
infect
one
exampl
guidelin
provid
societi
healthcar
epidemiolog
america
shea
includ
strategi
prevent
cdi
adult
adapt
pediatr
hematologyoncolog
patient
list
recommend
found
tabl
evalu
monitor
practic
provid
institut
complianc
data
well
identifi
area
improv
much
like
approach
taken
use
sp
bundl
analysi
done
use
approach
cdi
incid
remain
higher
institut
goal
shea
also
provid
special
approach
prevent
cdi
highrisk
set
data
indic
deviat
bundl
perform
data
increas
infect
opportun
improv
variou
action
must
taken
wide
varieti
caus
contribut
factor
must
consid
includ
staff
patient
famili
practic
equip
suppli
chang
environ
care
other
similar
area
patient
safeti
action
must
focu
high
leverag
chang
provid
fundament
last
chang
process
care
simpl
action
educ
polici
chang
may
provid
valu
situat
rare
provid
last
chang
improv
iter
ongo
improv
often
need
emb
last
chang
practic
leader
must
nimbl
respons
promot
chang
practic
particip
formal
collabor
across
children
hospit
focus
reduc
hai
becom
core
techniqu
qualiti
transform
network
manag
children
hospit
associ
cha
unifi
pediatr
hospit
work
togeth
order
deliv
highqual
reliabl
safe
care
pediatr
patient
initi
collabor
effort
prevent
hai
children
hospit
focus
clabsi
pediatr
intens
care
unit
picu
success
picu
work
prompt
cha
expand
effort
inpati
pediatr
hematologyoncolog
unit
ambulatori
set
creat
hematologyoncolog
clabsi
collabor
later
renam
childhood
cancer
blood
disord
learn
network
ccbdn
recent
cha
collabor
work
sp
sp
collect
data
inpati
tabl
basic
practic
prevent
monitor
cdi
recommend
acut
care
hospit
ambulatori
care
set
encourag
appropri
use
antimicrobi
initi
contact
precaut
patient
sign
symptom
consist
cdi
singlepati
room
prefer
implement
laboratorybas
alert
system
provid
immedi
notif
newli
diagnos
cdi
patient
educ
healthcar
personnel
environment
servic
personnel
hospit
administr
cdi
specif
import
handwash
soap
water
use
person
protect
equip
educ
patient
famili
cdi
appropri
includ
hand
hygien
clean
cell
phone
person
effect
clean
mainten
reusabl
medic
devic
accord
manufactur
instruct
institut
polici
reus
singleus
devic
establish
polici
procedur
routin
clean
disinfect
environment
surfac
inpati
ambulatori
care
facil
includ
place
emphasi
surfac
like
contamin
pathogen
use
eparegist
detergentsdisinfect
assess
adequaci
clean
notifi
receiv
caregiv
cdi
within
outsid
facil
upon
transfer
conduct
cdi
surveil
analyz
report
cdi
data
measur
complianc
cdc
hand
hygien
contact
precaut
clabsi
pediatr
oncologyhematolog
unit
ccbdn
concentr
effort
reduc
clabsi
ambulatori
patient
cancer
blood
disord
recogn
major
children
adolesc
receiv
much
care
outsid
hospit
clabsi
occur
twice
frequent
ambulatori
set
hospit
children
popul
ultim
prevent
hai
team
effort
requir
sustain
involv
engag
across
entir
healthcar
team
well
patient
famili
exampl
entir
team
routin
discuss
continu
need
intraven
urinari
cathet
pediatr
hematologyoncolog
popul
howev
care
may
requir
central
venou
cathet
month
year
time
reduc
line
access
nurs
physician
need
work
togeth
bundl
lab
draw
nurs
pharmacist
physician
need
work
togeth
switch
intraven
oral
therapi
ongo
commun
must
occur
environ
posit
patient
safeti
cultur
encourag
team
member
famili
speak
make
chang
patient
care
sustain
improv
achiev
reduc
healthcareassoci
infect
necessari
continu
obtain
success
outcom
pediatr
hematologyoncolog
patient
given
high
rate
infect
popul
associ
morbid
mortal
although
sustain
recogn
key
practic
qualiti
improv
safeti
work
includ
reduct
hai
pediatr
hematologyoncolog
patient
occur
automat
institut
healthcar
improv
refer
sustain
lock
progress
group
made
alreadi
continu
build
upon
pediatr
hematologyoncolog
patient
sustain
reduct
hai
impli
adopt
longterm
implement
establish
evidencebas
practic
known
result
infect
rate
reduct
becom
norm
within
group
ideal
adher
accomplish
ie
strict
complianc
central
line
care
bundl
reduc
clabsi
goal
develop
chang
reduc
pediatr
hai
endur
impact
even
initi
longer
top
prioriti
group
begin
function
without
addit
dedic
resourc
yet
maintain
posit
chang
longterm
known
high
rate
failur
limit
report
exist
sustain
healthcar
improv
factor
associ
difficulti
achiev
sustain
chang
specif
effort
aim
reduc
hai
pediatr
hematologyoncolog
patient
certainli
appli
includ
incorpor
new
staff
unawar
untrain
best
practic
develop
new
project
creat
distract
shift
focu
away
infect
reduct
complac
common
emerg
complex
case
group
patient
time
justifi
lack
adher
best
practic
therefor
specif
focu
sustain
necessari
order
hold
gain
achiev
strategi
sustain
must
incorpor
earli
embed
process
occur
insepar
process
design
test
implement
chang
improv
strategi
util
achiev
reduct
hai
also
lead
sustain
independ
formal
focu
aspect
care
plan
increas
chanc
maintain
improv
number
approach
foster
sustain
chang
base
high
reliabl
principl
describ
chapter
book
elsewher
mani
applic
preserv
chang
reduct
pediatr
hematologyoncolog
hai
obtain
limit
evid
exist
uniqu
sustain
particular
area
rather
effort
primarili
concentr
achiev
improv
reduc
hai
vulner
popul
rather
uphold
gain
organ
children
hospit
around
unit
state
largescal
pediatr
collabor
improv
network
overarch
principl
success
sustain
pediatr
qualiti
improv
safeti
effort
effort
pave
way
addit
healthcar
improv
safeti
initi
pediatr
hospit
turn
led
sustain
reduct
patient
harm
includ
fewer
pediatr
hai
first
visibl
success
stori
sustain
improv
specif
pediatr
cancer
blood
disord
patient
result
cha
ccbdn
effort
reduc
inpati
clabsi
pediatr
hematologyoncolog
patient
success
achiev
maintain
inpati
clabsi
rate
reduct
approxim
year
collabor
central
sustain
reduct
clabsi
rate
pediatr
hematologyoncolog
patient
spread
chang
hospit
collabor
network
encourag
share
success
stori
help
tool
strategi
achiev
maintain
reduct
clabsi
rate
addit
network
provid
platform
spread
expans
success
network
collabor
base
provid
common
forum
work
learn
improv
togeth
collabor
success
pediatr
hematologyoncolog
clabsi
reduct
highlight
number
strategi
central
sustain
chang
within
complex
popul
summar
three
categori
peopl
process
place
three
ps
similar
import
achiev
improv
strong
leadership
visibl
effect
central
sustain
chang
collabor
provid
high
level
individu
institut
also
requir
presenc
strong
leader
local
order
maintain
chang
achiev
larg
major
success
effort
reduc
clabsi
pediatr
hematologyoncolog
patient
emphas
import
dedic
team
direct
leadership
central
maintain
hospitalwid
support
even
goal
achiev
effort
continu
one
main
strategi
sustain
chang
primarili
reliant
staff
consist
perform
aspect
bundl
case
mani
pediatr
hai
prevent
effort
ensur
formal
ongo
staff
educ
train
newcom
best
practic
requir
highqual
train
staff
multidisciplinari
teamwork
commun
key
success
hold
gain
achiev
formal
compet
test
process
essenti
one
recommend
approach
ongo
formal
compet
test
fidel
simul
associ
assur
compet
care
deliveri
aspect
central
line
care
standard
spread
chang
key
aspect
sustain
aspect
also
observ
result
largescal
collabor
reduc
clabsi
pediatr
hematologyoncolog
patient
particip
children
hospit
across
nation
requir
continu
report
rate
infect
complianc
central
line
care
bundl
collabor
reproduc
detail
data
clabsi
bundl
complianc
rate
particip
center
allow
transpar
visibl
abil
gener
benchmark
data
facilit
comparison
among
center
furthermor
process
monitor
report
continu
even
reduct
clabsi
rate
observ
thu
serv
main
strategi
sustain
gain
monitor
report
infect
rate
incentiv
adher
best
practic
therefor
lead
sustain
reduct
rate
similarli
connect
team
hospit
reduc
trial
error
find
effect
solut
also
central
sustain
fact
initi
expect
long
term
built
persist
goal
achiev
qualiti
improv
maintain
pediatr
hematologyoncolog
clabsi
reduct
collabor
use
selfaudit
serv
measur
tool
also
remind
staff
regard
best
practic
care
central
line
strategi
encourag
strict
complianc
evidencebas
practic
standard
ongo
monitor
perform
incorpor
daili
routin
aspect
central
maintain
chang
strategi
use
includ
develop
process
learn
outstand
scenario
rca
identifi
local
barrier
methodolog
failur
mode
effect
analysi
strategi
use
prospect
identifi
area
risk
one
group
specif
describ
import
ongo
monitor
infect
rate
need
process
place
respond
unexpect
chang
face
observ
rise
clabsi
rate
strategi
includ
preemptiv
identifi
patient
clabsispecif
risk
factor
identif
variabl
associ
increas
clabsi
rate
directli
frontlin
staff
evalu
variabl
associ
increas
microsystem
stress
embed
everi
improv
process
meant
last
need
promot
cultur
chang
pediatr
hematologyoncolog
reduc
hai
requir
nation
intern
focu
help
identifi
sever
problem
conclud
improv
achiev
largescal
collabor
led
sustain
reduct
pediatr
hematologyoncolog
clabsi
directli
indirectli
contribut
cultur
chang
emphasi
reduc
hai
collect
led
increas
awar
problem
key
step
develop
cultur
chang
also
indirectli
led
increas
attent
detail
contribut
focu
safeti
cultur
chang
belief
system
summari
attitud
toward
infecti
complic
pediatr
hematologyoncolog
care
evolv
past
decad
belief
ill
larg
inevit
understand
dilig
adher
best
practic
incid
mani
common
infect
pediatr
hematologyoncolog
patient
transplant
recipi
significantli
reduc
effort
individu
institut
critic
identifi
risk
infect
popul
new
strategi
infect
prevent
ensur
organ
maintain
complianc
standard
largescal
collabor
provid
forum
test
new
intervent
dissemin
standard
evidencebas
infect
prevent
method
develop
measur
monitor
process
benchmark
improv
although
still
rel
new
effort
systemat
incorpor
qualiti
improv
strategi
alreadi
demonstr
great
promis
reduc
morbid
mortal
associ
infect
children
adolesc
cancer
improv
diseas
outcom
